Logo image of BIRD

ALLBIRDS INC-CL A (BIRD) Stock Fundamental Analysis

USA - NASDAQ:BIRD - US01675A2087 - Common Stock

6.74 USD
-0.09 (-1.32%)
Last: 10/22/2025, 11:01:00 AM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BIRD. BIRD was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of BIRD is average, but there are quite some concerns on its profitability. BIRD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BIRD had negative earnings in the past year.
In the past year BIRD has reported a negative cash flow from operations.
In the past 5 years BIRD always reported negative net income.
In the past 5 years BIRD always reported negative operating cash flow.
BIRD Yearly Net Income VS EBIT VS OCF VS FCFBIRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -61.56%, BIRD is doing worse than 93.75% of the companies in the same industry.
With a Return On Equity value of -118.04%, BIRD is not doing good in the industry: 89.58% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -61.56%
ROE -118.04%
ROIC N/A
ROA(3y)-40.03%
ROA(5y)-28%
ROE(3y)-68.68%
ROE(5y)-46.4%
ROIC(3y)N/A
ROIC(5y)N/A
BIRD Yearly ROA, ROE, ROICBIRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 39.33%, BIRD is doing worse than 70.83% of the companies in the same industry.
BIRD's Gross Margin has declined in the last couple of years.
BIRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.86%
GM growth 5Y-3.48%
BIRD Yearly Profit, Operating, Gross MarginsBIRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BIRD has more shares outstanding
The number of shares outstanding for BIRD has been reduced compared to 5 years ago.
There is no outstanding debt for BIRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BIRD Yearly Shares OutstandingBIRD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
BIRD Yearly Total Debt VS Total AssetsBIRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

BIRD has an Altman-Z score of -5.13. This is a bad value and indicates that BIRD is not financially healthy and even has some risk of bankruptcy.
BIRD has a Altman-Z score of -5.13. This is amonst the worse of the industry: BIRD underperforms 89.58% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that BIRD is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.07, BIRD belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -5.13
ROIC/WACCN/A
WACC10.64%
BIRD Yearly LT Debt VS Equity VS FCFBIRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

BIRD has a Current Ratio of 2.55. This indicates that BIRD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.55, BIRD is in the better half of the industry, outperforming 77.08% of the companies in the same industry.
A Quick Ratio of 1.41 indicates that BIRD should not have too much problems paying its short term obligations.
BIRD's Quick ratio of 1.41 is fine compared to the rest of the industry. BIRD outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.41
BIRD Yearly Current Assets VS Current LiabilitesBIRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

BIRD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.77%, which is quite good.
BIRD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.48%.
The Revenue has been decreasing by -0.41% on average over the past years.
EPS 1Y (TTM)18.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-22.48%
Revenue growth 3Y-11.9%
Revenue growth 5Y-0.41%
Sales Q2Q%-23.06%

3.2 Future

BIRD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.37% yearly.
BIRD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.18% yearly.
EPS Next Y17.19%
EPS Next 2Y16.72%
EPS Next 3Y18.37%
EPS Next 5YN/A
Revenue Next Year-11.79%
Revenue Next 2Y-3.92%
Revenue Next 3Y-0.18%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BIRD Yearly Revenue VS EstimatesBIRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 100M 200M 300M 400M 500M
BIRD Yearly EPS VS EstimatesBIRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

BIRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BIRD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIRD Price Earnings VS Forward Price EarningsBIRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIRD Per share dataBIRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as BIRD's earnings are expected to grow with 18.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.72%
EPS Next 3Y18.37%

0

5. Dividend

5.1 Amount

BIRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALLBIRDS INC-CL A

NASDAQ:BIRD (10/22/2025, 11:01:00 AM)

6.74

-0.09 (-1.32%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)N/A N/A
Inst Owners46.32%
Inst Owner Change0%
Ins Owners2.86%
Ins Owner Change0%
Market Cap54.93M
Revenue(TTM)170.65M
Net Income(TTM)-84231000
Analysts77.78
Price Target11.22 (66.47%)
Short Float %17.31%
Short Ratio15.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.08%
Min EPS beat(2)28.09%
Max EPS beat(2)30.07%
EPS beat(4)4
Avg EPS beat(4)20.8%
Min EPS beat(4)7.68%
Max EPS beat(4)30.07%
EPS beat(8)8
Avg EPS beat(8)22.61%
EPS beat(12)12
Avg EPS beat(12)19.47%
EPS beat(16)13
Avg EPS beat(16)8.35%
Revenue beat(2)2
Avg Revenue beat(2)2.85%
Min Revenue beat(2)0.79%
Max Revenue beat(2)4.91%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)4.91%
Revenue beat(8)5
Avg Revenue beat(8)-0.07%
Revenue beat(12)8
Avg Revenue beat(12)0.36%
Revenue beat(16)9
Avg Revenue beat(16)0.33%
PT rev (1m)0%
PT rev (3m)15.79%
EPS NQ rev (1m)1.02%
EPS NQ rev (3m)-11.53%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)1.41%
Revenue NQ rev (1m)-7.91%
Revenue NQ rev (3m)-18.27%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-4.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-10.56
EYN/A
EPS(NY)-7.47
Fwd EYN/A
FCF(TTM)-7.57
FCFYN/A
OCF(TTM)-7.2
OCFYN/A
SpS20.94
BVpS8.76
TBVpS8.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.56%
ROE -118.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.33%
FCFM N/A
ROA(3y)-40.03%
ROA(5y)-28%
ROE(3y)-68.68%
ROE(5y)-46.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.86%
GM growth 5Y-3.48%
F-Score2
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.28%
Cap/Sales 1.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 1.41
Altman-Z -5.13
F-Score2
WACC10.64%
ROIC/WACCN/A
Cap/Depr(3y)99.47%
Cap/Depr(5y)150.28%
Cap/Sales(3y)5.66%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y17.19%
EPS Next 2Y16.72%
EPS Next 3Y18.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.48%
Revenue growth 3Y-11.9%
Revenue growth 5Y-0.41%
Sales Q2Q%-23.06%
Revenue Next Year-11.79%
Revenue Next 2Y-3.92%
Revenue Next 3Y-0.18%
Revenue Next 5YN/A
EBIT growth 1Y19.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.8%
EBIT Next 3Y22.47%
EBIT Next 5YN/A
FCF growth 1Y9.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.38%
OCF growth 3YN/A
OCF growth 5YN/A